Danieli Barino Salinas1, Colleen Azen2, Suzanne Young3, Thomas G Keens1, Martin Kharrazi4, Richard B Parad5. 1. 1 Department of Pediatric Pulmonology, Keck School of Medicine, Children's Hospital Los Angeles, University of Southern California , Los Angeles, California. 2. 2 Department of Biostatics, Southern California Clinical and Translational Science Institute, Children's Hospital Los Angeles, University of Southern California , Los Angeles, California. 3. 3 Sequoia Foundation , La Jolla, California. 4. 4 Environmental Health Investigations Branch , California Department of Public Health, Richmond, California. 5. 5 Department of Pediatric Newborn Medicine, Brigham and Women's Hospital , Harvard Medical School, Boston, Massachusetts.
Abstract
BACKGROUND: At the cystic fibrosis transmembrane conductance regulator (CFTR) gene (IVS8)-(TG)m(T)n locus, a lower number of thymidines (legacy names 9T vs. 7T vs. 5T) and a higher number of (TG) repeats (TG-11 vs. 12 vs. 13) are associated with decreasing translation of functional CFTR protein in vitro. METHODS: Retrospective cohort study comparing phenotypes of California CF newborn screen-positive children (followed 2-8 years) who had two CF-causing mutations (diagnosed as CF) with those who had one mutation from a panel of 40 CF-causing mutations (CF40mut) and one (IVS8)-(TG)11, 12, or 13-5T mutation detected by sequencing (diagnosed as CFTR-related metabolic syndrome [cRMS]). RESULTS: The study included 428 children, of which 234 had two CF-causing mutations, and were used to compare with the other 194 children with one CF-causing mutation and one isolated 5T allele [CF40mut/(TG)13-5T = 21, CF40mut/(TG)12-5T = 85, and CF40mut/(TG)11-5T = 88]. Among children with CF40mut/(TG)13-5T, 38% were diagnosed with CF by 8 years, based on sweat chloride results and clinical presentation. Six percent of those with CF40mut/(TG)12-5T, and none with CF40mut/(TG)11-5T, reached diagnostic criteria. CONCLUSIONS: CFTR (IVS8)-(TG)m-5T allele (TG) tract length determination provides valuable information in predicting the risk of developing a CF phenotype. Of the three types of 5T alleles evaluated, screen-positive children with genotype CF40mut/(TG)13-5T progressed from CRMS to CF at a high rate, while there was little evidence of clinical disease in those with CF40mut/(TG)11-5T. Additional data from longer follow-up intervals are needed to fully understand the natural history of individuals with a CF40mut/(TG)m-5T genotype.
BACKGROUND: At the cystic fibrosis transmembrane conductance regulator (CFTR) gene (IVS8)-(TG)m(T)n locus, a lower number of thymidines (legacy names 9T vs. 7T vs. 5T) and a higher number of (TG) repeats (TG-11 vs. 12 vs. 13) are associated with decreasing translation of functional CFTR protein in vitro. METHODS: Retrospective cohort study comparing phenotypes of California CF newborn screen-positive children (followed 2-8 years) who had two CF-causing mutations (diagnosed as CF) with those who had one mutation from a panel of 40 CF-causing mutations (CF40mut) and one (IVS8)-(TG)11, 12, or 13-5T mutation detected by sequencing (diagnosed as CFTR-related metabolic syndrome [cRMS]). RESULTS: The study included 428 children, of which 234 had two CF-causing mutations, and were used to compare with the other 194 children with one CF-causing mutation and one isolated 5T allele [CF40mut/(TG)13-5T = 21, CF40mut/(TG)12-5T = 85, and CF40mut/(TG)11-5T = 88]. Among children with CF40mut/(TG)13-5T, 38% were diagnosed with CF by 8 years, based on sweat chloride results and clinical presentation. Six percent of those with CF40mut/(TG)12-5T, and none with CF40mut/(TG)11-5T, reached diagnostic criteria. CONCLUSIONS:CFTR (IVS8)-(TG)m-5T allele (TG) tract length determination provides valuable information in predicting the risk of developing a CF phenotype. Of the three types of 5T alleles evaluated, screen-positive children with genotype CF40mut/(TG)13-5T progressed from CRMS to CF at a high rate, while there was little evidence of clinical disease in those with CF40mut/(TG)11-5T. Additional data from longer follow-up intervals are needed to fully understand the natural history of individuals with a CF40mut/(TG)m-5T genotype.
Authors: Drucy Borowitz; Richard B Parad; Jack K Sharp; Kathryn A Sabadosa; Karen A Robinson; Michael J Rock; Philip M Farrell; Marci K Sontag; Margaret Rosenfeld; Stephanie D Davis; Bruce C Marshall; Frank J Accurso Journal: J Pediatr Date: 2009-12 Impact factor: 4.406
Authors: Danieli Barino Salinas; Patrick R Sosnay; Colleen Azen; Suzanne Young; Karen S Raraigh; Thomas G Keens; Martin Kharrazi Journal: J Cyst Fibros Date: 2015-03-29 Impact factor: 5.482
Authors: C Bombieri; M Claustres; K De Boeck; N Derichs; J Dodge; E Girodon; I Sermet; M Schwarz; M Tzetis; M Wilschanski; C Bareil; D Bilton; C Castellani; H Cuppens; G R Cutting; P Drevínek; P Farrell; J S Elborn; K Jarvi; B Kerem; E Kerem; M Knowles; M Macek; A Munck; D Radojkovic; M Seia; D N Sheppard; K W Southern; M Stuhrmann; E Tullis; J Zielenski; P F Pignatti; C Ferec Journal: J Cyst Fibros Date: 2011-06 Impact factor: 5.482
Authors: Timothy W Hefferon; Joshua D Groman; Catherine E Yurk; Garry R Cutting Journal: Proc Natl Acad Sci U S A Date: 2004-03-01 Impact factor: 11.205
Authors: Drucy Borowitz; Karen A Robinson; Margaret Rosenfeld; Stephanie D Davis; Kathryn A Sabadosa; Stephanie L Spear; Suzanne H Michel; Richard B Parad; Terry B White; Philip M Farrell; Bruce C Marshall; Frank J Accurso Journal: J Pediatr Date: 2009-12 Impact factor: 4.406
Authors: Anja Kammesheidt; Martin Kharrazi; Steve Graham; Suzanne Young; Michelle Pearl; Charles Dunlop; Steven Keiles Journal: Genet Med Date: 2006-09 Impact factor: 8.822
Authors: Charles M Strom; Donghui Huang; Christina Chen; Arlene Buller; Mei Peng; Franklin Quan; Joy Redman; Weimin Sun Journal: Genet Med Date: 2003 Jan-Feb Impact factor: 8.822
Authors: Vito Terlizzi; Rita Padoan; Laura Claut; Carla Colombo; Benedetta Fabrizzi; Marco Lucarelli; Sabina Maria Bruno; Alice Castaldo; Paolo Bonomi; Giovanni Taccetti; Antonella Tosco Journal: Diagnostics (Basel) Date: 2020-12-12
Authors: Keith Nykamp; Rebecca Truty; Darlene Riethmaier; Julia Wilkinson; Sara L Bristow; Sienna Aguilar; Dana Neitzel; Nicole Faulkner; Swaroop Aradhya Journal: Hum Mutat Date: 2021-07-10 Impact factor: 4.700